You can now read 10 articles each month for free on BostonGlobe.com.

The Boston Globe

Business

Alnylam, Medicines Co. in deal with cholesterol drug

The Medicines Co. is licensing the rights to a powerful type of cholesterol-lowering drug from Cambridge-based Alnylam­ Pharmaceuticals, entering one of the hottest races in the industry.

The drug, ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor.

Loading comments...

You have reached the limit of 10 free articles a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than $1 a week